Log In
Print
BCIQ
Print
Print this Print this
 

MIN-101

  Manage Alerts
Collapse Summary General Information
Company Minoryx Therapeutics S.L.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationLeukodystrophy
Indication DetailsTreat X-linked adrenoleukodystrophy (ALD)
Regulatory Designation

EU - Orphan Drug (Treat X-linked adrenoleukodystrophy (ALD))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today